Song Hong Fang's Form 4 filing
CG Oncology, Inc. (CGON) · filed Sep 4, 2025
- Accession no.
- 0002008157-25-000004
- Filed
- Sep 4, 2025
- Trade date
- Sep 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.78M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Song Hong FangCIK 0002008157 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Common Stock | SSaleDisposed | −69,695 | $27.60 | −$1,923,582 | 2,934,236 | Indirect | |
| Sep 3, 2025 | Common Stock | SSaleDisposed | −30,105 | $28.24 | −$850,165.2 | 2,904,131 | Indirect | |
| Sep 3, 2025 | Common Stock | SSaleDisposed | −100 | $28.96 | −$2,896 | 2,904,031 | Indirect | |
| Sep 3, 2025 | Common Stock | SSaleDisposed | −100 | $28.99 | −$2,899 | 2,903,931 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.